WallStreetZenWallStreetZen

NASDAQ: GRCL
Gracell Biotechnologies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for GRCL

Based on 4 analysts offering 12 month price targets for Gracell Biotechnologies Inc.
Min Forecast
$11.00+324.71%
Avg Forecast
$16.00+517.76%
Max Forecast
$20.00+672.2%

Should I buy or sell GRCL stock?

Based on 4 analysts offering ratings for Gracell Biotechnologies Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GRCL stock forecasts and price targets.

GRCL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Bottom 3%
3
Strong BuyReiterates$20.00+672.20%2023-09-05
Citigroup
Bottom 3%
3
Strong BuyMaintains$11.00+324.71%2023-08-29
HC Wainwright & Co.
Top 24%
77
BuyMaintains$13.00+401.93%2023-08-14
BTIG
Bottom 8%
8
Strong BuyMaintains$20.00+672.20%2023-06-13Find out why

1 of 1

Forecast return on equity

Is GRCL forecast to generate an efficient return?
Company
N/A
Industry
0.66%
Market
28.71%

Forecast return on assets

Is GRCL forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.05%

GRCL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GRCL$2.59$16.00+517.76%Strong Buy
MACK$12.26N/AN/A
VIGL$4.97$23.50+372.84%Buy
OMER$2.77N/AN/A
RIGL$1.03$8.50+725.24%Buy
View Top Biotech Stocks

Gracell Biotechnologies Stock Forecast FAQ

Is Gracell Biotechnologies Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: GRCL) stock is to Strong Buy GRCL stock.

Out of 4 analysts, 3 (75%) are recommending GRCL as a Strong Buy, 1 (25%) are recommending GRCL as a Buy, 0 (0%) are recommending GRCL as a Hold, 0 (0%) are recommending GRCL as a Sell, and 0 (0%) are recommending GRCL as a Strong Sell.

If you're new to stock investing, here's how to buy Gracell Biotechnologies stock.

What is GRCL's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: GRCL) forecast ROE is N/A, which is considered weak.

What is GRCL's Price Target?

According to 4 Wall Street analysts that have issued a 1 year GRCL price target, the average GRCL price target is $16.00, with the highest GRCL stock price forecast at $20.00 and the lowest GRCL stock price forecast at $11.00.

On average, Wall Street analysts predict that Gracell Biotechnologies's share price could reach $16.00 by Sep 5, 2024. The average Gracell Biotechnologies stock price prediction forecasts a potential upside of 517.76% from the current GRCL share price of $2.59.

What is GRCL's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: GRCL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.05%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.